Bellerophon Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
24.50
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.58
|
-0.53
|
0.05
|
8.62%
|
|
2022-06-30
|
-0.60
|
-0.43
|
0.17
|
28.33%
|
|
2022-03-31
|
-0.55
|
-0.59
|
-0.04
|
-7.27%
|
|
2021-12-31
|
-0.60
|
-0.45
|
0.15
|
25.00%
|
|
2021-09-30
|
-0.63
|
-0.49
|
0.14
|
22.22%
|
|
2021-06-30
|
-0.66
|
-0.36
|
0.30
|
45.45%
|
|
2021-03-31
|
-0.71
|
-0.58
|
0.13
|
18.31%
|
|
2020-12-31
|
-0.90
|
-0.86
|
0.04
|
4.44%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.55
|
|
2021-12-31
|
-1.88
|
|
2020-12-31
|
-3.21
|
|
2019-12-31
|
-2.95
|
|
2018-12-31
|
-4.50
|
|
2017-12-31
|
-2.94
|
|
2016-12-31
|
-1.59
|
|
2015-12-31
|
-3.85
|
|
2014-12-31
|
-1.62
|